GO
Loading...

Ariad Takes Off

Tuesday, 6 Mar 2012 | 2:42 PM ET

Harvey Berger, Ariad Pharmaceuticals chairman & CEO, discusses pending FDA approval of its two commercial cancer drugs and what is driving the boom in the stock.